Compounds > 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and daunorubicin

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with daunorubicin in 1 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Studies
(daunorubicin)		Trials
(daunorubicin)		Recent Studies (post-2010) (daunorubicin)
9,1561875528,2398861,310

Protein Interaction Comparison

ProteinTaxonomy1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50)daunorubicin (IC50)
72 kDa type IV collagenaseHomo sapiens (human)1.9
Multidrug resistance-associated protein 1 Homo sapiens (human)8
Histone deacetylase 1Homo sapiens (human)0.047
Histone deacetylase 8Homo sapiens (human)0.22
Histone deacetylase 6Homo sapiens (human)0.02

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and daunorubicin

ArticleYear
Immunomodulation: other approaches.
    Transplantation proceedings, 1988, Volume: 20, Issue:1 Suppl 1

    Topics: Animals; Daunorubicin; Female; Graft Enhancement, Immunologic; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Mice; Multiple Sclerosis; Placenta; Platelet Activating Factor; Pregnancy; Rabbits; Rats; Transplantation Immunology

1988